Dexmedetomidine,Ketamine,Butorphanol
111 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
111
Total Reports
14
Deaths Reported
1260.0%
Death Rate
Active Ingredients
Dexmedetomidine,Ketamine,Butorphanol
Administration Routes
UnknownParenteralIntramuscularOther
Species Affected
Cat 109
Dog 2
Most Affected Breeds
Domestic Shorthair 72
Domestic Longhair 9
Cat (unknown) 8
Domestic Mediumhair 8
Siamese 5
Dog (unknown) 1
British cat 1
Bengal 1
Rex (unspecified) 1
Scottish Fold Shorthair 1
Most Reported Reactions
Behavioural disorder NOS 21
Hyperactivity 18
Dilated pupils 14
Not eating 12
Dysphoria 12
Elevated temperature 11
Lethargy (see also Central nervous system depression in Neurological) 10
Hiding 9
Not sleeping 9
Application site alopecia 8
Seizure NOS 7
Weight loss 7
Outcome Breakdown
Ongoing
38 (34.2%)
Recovered/Normal
32 (28.8%)
Outcome Unknown
27 (24.3%)
Euthanized
7 (6.3%)
Died
7 (6.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.